MastersEL. 26. Knowlt Hoheimer (Pro Patria). The Spoon River Anthology. The Macmillan Company, New York. 1916.
2.
SchulzKFChalmersIAltmanDG. The Landscape and lexicon of blinding in randomized trials. Ann Intern Med2002; 136: 254–59.
3.
BoutronIEstellatCRavaudP. A review of blinding in randomized controlled trials found results inconsistent and questionable. J Clin Epidemiol2005; 58: 1220–26.
4.
FergussonDGlassKCWaringDShapiroS. Turning a blind eye: the success of blinding reported in a random sample of placebo controlled trials. BMJ2004; 328: 432–36.
5.
HrobjartssonAForfangEHaahrMT. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol2007; 36: 654–67.
6.
The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med1978; 299: 53–59.
7.
SackettDL. Commentary: measuring the success of blinding in RCTs: don't, must, can't or needn't?Int J Epidemiol2007; 36: 664–65.
8.
Senn SJ. A blinkered view of blinding. BMJ Rapid Response of 20 February 2004. doi:10.1136/bmj.328. 74327.37952.631667.EE.
9.
SchulzKFAltmanDGMoherDFergussonD. CONSORT 2010 changes and testing blindness in RCTs. Lancet2010; 375: 1144–46.
10.
SackettDL. Clinician-trialist rounds 5. Cointervention bias – how to diagnose it in their trial and prevent it in yours. Clin Trialsin press.
11.
The FIELD Study Investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet2005; 366: 1849–61.
12.
NoseworthyJHEbersGCVandervoortMK. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology1994; 44: 16–20.
